https://www.cnbc.com/2021/09/01/tsa-airport-screenings-drop-to-lowest-since-may-as-travel-and-fares-fall.html
AstraZeneca’s Forxiga Wins European Approval For Chronic Kidney Disease
The European Union has approved AstraZeneca plc’s (NASDAQ:AZN) Forxiga (dapagliflozin) for chronic kidney disease (CKD) in adults with and without type-2…